Portfolio Companies
About Us
Xyence Capital è una società di gestione del risparmio che investe in persone, idee e tecnologie in grado di trasformare il futuro delle scienze della vita.
We work together with entrepreneurs and researchers to develop revolutionary companies that improve human health.
We support ambitious start-ups and early-stage SMEs with innovative products globally, primarily in Europe and the United States.
Principia II Fund
It has completed 30 investments and currently has 2 operating companies in its portfolio
Principia III – Health Fund
It has completed a total of 16 investments.
There are currently 9 portfolio companies operating in the Biopharma, Medical Device, Healthcare Services and Digital Health sectors
Team
Luca Marini
Chief Executive Officer & Board Member
Sergio Buonanno
Board President
Stefano Mezzadri
Board Member
Jacopo Zannoni
Analyst
Melissa Cannone
Chief Financial Officer
Luca Longo
Board Member
Francesca Perrotti
Corporate Affairs Manager
Portfolio
Principia II Fund
Digital publishing
Principia III – Health Fund
NEWS
CheckmAb and Boehringer Ingelheim Collaborate to Develop Novel Immunotherapy for Cancer Patients
